1
|
Sager P, Kaiser A, Schumann S, Ludescher B, Brysch W. Efficacy of MP1032 in hospitalised patients with COVID-19- authors' reply. THE LANCET REGIONAL HEALTH. EUROPE 2024; 38:100857. [PMID: 38328414 PMCID: PMC10848025 DOI: 10.1016/j.lanepe.2024.100857] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/19/2024] [Accepted: 01/19/2024] [Indexed: 02/09/2024]
Affiliation(s)
- Petra Sager
- MetrioPharm Deutschland GmbH, Am Borsigturm 100, 13507, Berlin, Germany
| | - Astrid Kaiser
- MetrioPharm Deutschland GmbH, Am Borsigturm 100, 13507, Berlin, Germany
| | - Sara Schumann
- MetrioPharm Deutschland GmbH, Am Borsigturm 100, 13507, Berlin, Germany
| | - Beate Ludescher
- MetrioPharm Deutschland GmbH, Am Borsigturm 100, 13507, Berlin, Germany
| | - Wolfgang Brysch
- MetrioPharm Deutschland GmbH, Am Borsigturm 100, 13507, Berlin, Germany
- MetrioPharm AG, Europaallee 41, Zurich, 8004, Switzerland
| |
Collapse
|